Aurobindo Pharma receives EIR from USFDA for its Andhra Pradesh facility
NEW DELHI: Aurobindo Pharma Ltd on Wednesday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility at Pydibhimavaram in Andhra Pradesh. The company’s Unit XI at Pydibhimavaram is an API non-antibiotic manufacturing facility. It was inspected by the US Food and Drug Administration (USFDA) in February […]
Aurobindo Pharma net profit dips 22% to Rs 604 crore in December quarter
NEW DELHI: Aurobindo Pharma on Wednesday said its consolidated net profit declined by 22.3 per cent to Rs 604.29 crore for the third quarter ended December 31, 2021, hit by high input and freight costs. The Hyderabad-based drug maker had reported a consolidated net profit of Rs 777.3 crore in the same period of previous […]
Aurobindo Pharma expects to commercialise Covid-19 vaccine facility by May
NEW DELHI: Aurobindo Pharma expects to commercialise its vaccine manufacturing facility in Hyderabad by April-May next year, according to a top company official. The Hyderabad-based drug major is investing around Rs 275 crore on the facility which would be utilised to produce vaccines for the treatment of various viral diseases including COVID-19. Besides developing its […]
Aurobindo Pharma arm’s New Jersey unit gets warning letter from USFDA
NEW DELHI: Drug firm Aurobindo Pharma Thursday said its step-down subsidiary has received a warning letter from the US health regulator for its unit in New Jersey, US. AuroLife Pharma, a wholly-owned step-down subsidiary of the company, has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral solid […]
Aurobindo Pharma gets USFDA nod for infections treatment drug
NEW DELHI: Drug firm Aurobindo Pharma on Thursday said it has received final nod from the US health regulator for its Azithromycin oral suspension used for treatment of infections. The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin oral suspension 100 mg /5 mL and […]